Literature DB >> 33105129

Biomarkers of Unfavorable Outcome in Acute Ischemic Stroke Patients with Successful Recanalization by Endovascular Thrombectomy.

Nailiang Zang1, Zhenzhou Lin1, Kaibin Huang1, Yue Pan1, Yanan Wu1, Yongming Wu1, Shengnan Wang1, Dongmei Wang1, Zhong Ji1, Suyue Pan2.   

Abstract

BACKGROUND: We aimed to identify plasma markers of unfavorable outcomes for patients with acute ischemic stroke (AIS) after recanalization by endovascular thrombectomy (EVT).
METHODS: From November 2017 to May 2019, we prospectively collected 61 AIS patients due to anterior large vessel occlusion who achieved recanalization by EVT. Plasma samples were obtained between 18 and 24 h after recanalization. Unfavorable outcomes included futile recanalization at 90 days and overall early complications within 7 days after EVT.
RESULTS: After adjustment for age and initial National Institute of Health Stroke Scale (NIHSS), matrix metalloproteinase-9 (MMP-9), tenascin-C, thioredoxin, ADAMTS13, and gelsolin were independently associated with both futile recanalization and overall early complications significantly (all p < 0.05), while C-reactive protein (CRP) was independently associated with overall early complications (p = 0.031) but at the limit of significance for futile recanalization (p = 0.051). The baseline clinical model (BCM) (including age and initial NIHSS) demonstrated discriminating ability to indicate futile recanalization (area under the curve [AUC] 0.807, 95% confidence interval [CI] 0.693-0.921) and overall early complications (AUC 0.749, 95% CI 0.611-0.887). BCM+MMP-9+thioredoxin enhanced discrimination (AUC 0.908, 95% CI 0.839-0.978, p = 0.043) and reclassification (net reclassification improvement [NRI] 67.2%, p < 0.001) to indicate futile recanalization. With respect to overall early complications, BCM+MMP-9+tenascin-C, BCM+MMP-9+CRP, BCM+MMP-9+ADAMTS13, BCM+tenascin-C+ADAMTS13, and BCM+CRP+ADAMTS13, all improved discrimination (AUC [95% CI]: 0.868 [0.766-0.970], 0.882 [0.773-0.990], 0.886 [0.788-0.984], 0.880 [0.783-0.977], and 0.863 [0.764-0.962], respectively, all p < 0.05 by the DeLong method) and reclassification (NRI 59.1%, 71.8%, 51.1%, 67.4%, and 38.3%, respectively, all p < 0.05).
CONCLUSIONS: The increased levels of MMP-9, tenascin-C, CRP, thioredoxin, and decreased levels of ADAMTS13 and gelsolin were independent predictors of futile recanalization in AIS patients after recanalization by EVT.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Acute ischemic stroke; Biomarkers; Early complication; Endovascular thrombectomy; Futile recanalization

Year:  2020        PMID: 33105129     DOI: 10.1159/000510804

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

1.  High serum total cholesterol associated with good outcome in endovascular thrombectomy for acute large artery occlusion.

Authors:  Sang Hee Ha; Jae-Chan Ryu; Jae-Han Bae; Sujin Koo; Boseong Kwon; Yunsun Song; Deok Hee Lee; Jun Young Chang; Dong-Wha Kang; Sun U Kwon; Jong S Kim; Bum Joon Kim
Journal:  Neurol Sci       Date:  2022-07-13       Impact factor: 3.830

Review 2.  Composition and Organization of Acute Ischemic Stroke Thrombus: A Wealth of Information for Future Thrombolytic Strategies.

Authors:  Jean-Philippe Desilles; Lucas Di Meglio; Francois Delvoye; Benjamin Maïer; Michel Piotin; Benoît Ho-Tin-Noé; Mikael Mazighi
Journal:  Front Neurol       Date:  2022-07-06       Impact factor: 4.086

3.  Plasma Lipid Mediators Associate With Clinical Outcome After Successful Endovascular Thrombectomy in Patients With Acute Ischemic Stroke.

Authors:  Jiheng Hao; Yao Feng; Xin Xu; Long Li; Kun Yang; Gaolei Dai; Weiwei Gao; Meng Zhang; Yaming Fan; Tengkun Yin; Jiyue Wang; Bin Yang; Liqun Jiao; Liyong Zhang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

4.  Perspectives on effect of spleen in ischemic stroke.

Authors:  Yarong Ding; Donald DeGracia; Xiaokun Geng; Yuchuan Ding
Journal:  Brain Circ       Date:  2022-09-21

5.  Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.

Authors:  Xin Xu; Weiwei Gao; Lei Li; Jiheng Hao; Bin Yang; Tao Wang; Long Li; Xuesong Bai; Fanjian Li; Honglei Ren; Meng Zhang; Liyong Zhang; Jiyue Wang; Dong Wang; Jianning Zhang; Liqun Jiao
Journal:  J Neuroinflammation       Date:  2021-05-22       Impact factor: 8.322

Review 6.  Translational Stroke Research Review: Using the Mouse to Model Human Futile Recanalization and Reperfusion Injury in Ischemic Brain Tissue.

Authors:  Emilia Conti; Benedetta Piccardi; Alessandro Sodero; Laura Tudisco; Ivano Lombardo; Enrico Fainardi; Patrizia Nencini; Cristina Sarti; Anna Letizia Allegra Mascaro; Marzia Baldereschi
Journal:  Cells       Date:  2021-11-25       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.